What are the most common IV antibiotics for treating cellulitis?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: July 6, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

From the Guidelines

The most common IV antibiotics for treating cellulitis are vancomycin, cefazolin, and linezolid, with vancomycin being a preferred option for suspected MRSA infections, as recommended by the Infectious Diseases Society of America 1. When treating cellulitis, it's essential to consider the severity of the infection, the presence of systemic signs, and the potential for MRSA.

  • For patients with severe infections or those who are hospitalized, IV vancomycin is often the first-line choice, dosed at 15-20mg/kg IV every 12 hours 1.
  • Cefazolin is another option, typically dosed at 1-2g IV every 8 hours, and is effective against methicillin-sensitive Staphylococcus aureus (MSSA) and streptococci 1.
  • Linezolid, dosed at 600mg IV every 12 hours, is also a viable option, especially for patients with suspected MRSA infections 1. Key considerations when administering these medications include monitoring renal function, especially with vancomycin, and assessing for clinical improvement within 48-72 hours 1. If no improvement occurs, broadening coverage or investigating for deeper infection may be necessary. These antibiotics target the bacterial cell wall or protein synthesis, effectively eliminating the infection while the body's immune system helps clear the remaining bacteria. Treatment duration typically ranges from 5-14 days, depending on clinical response, with many patients transitioning to oral antibiotics once improvement is seen 1.

From the Research

Most Common IV Antibiotics for Treating Cellulitis

  • Cefazolin is a commonly used IV antibiotic for treating cellulitis, as seen in studies 2, 3, 4, 5
  • Ceftriaxone is another IV antibiotic used to treat cellulitis, as compared to cefazolin in study 2
  • Ampicillin/sulbactam is also used to treat skin and skin-structure infections, including cellulitis, as seen in study 6
  • Cefoxitin is used to treat other skin and skin-structure infections, as seen in study 6

Treatment Regimens

  • Once-daily IV cefazolin plus oral probenecid is a effective treatment option for moderate-to-severe cellulitis, as seen in study 2
  • Twice-daily cefazolin 2 g IV is a convenient and effective option for home-based treatment of patients with cellulitis, as seen in study 4
  • The duration of antibiotic therapy for cellulitis can be affected by factors such as patient age, C-reactive protein levels, presence of diabetes mellitus, and presence of blood stream infection, as seen in study 5

Efficacy and Safety

  • Cefazolin has been shown to be effective in treating cellulitis, with clinical cure rates of 86% to 96%, as seen in studies 2, 4
  • Ceftriaxone has also been shown to be effective in treating cellulitis, with clinical cure rates of 96%, as seen in study 2
  • Ampicillin/sulbactam and cefoxitin have been shown to be effective in treating skin and skin-structure infections, including cellulitis, as seen in study 6

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Home-based treatment of cellulitis with twice-daily cefazolin.

The Medical journal of Australia, 1998

Research

Factors that affect the duration of antimicrobial therapy for cellulitis.

Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy, 2018

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.